[O2–09–02]: EVALUATION OF SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDI1814, A BETA‐AMYLOID 42 (Aβ42)‐SPECIFIC ANTIBODY, IN PATIENTS WITH MILD‐MODERATE ALZHEIMER'S DISEASE. (1st July 2017)

Record Type:: Journal Article
Title:: [O2–09–02]: EVALUATION OF SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDI1814, A BETA‐AMYLOID 42 (Aβ42)‐SPECIFIC ANTIBODY, IN PATIENTS WITH MILD‐MODERATE ALZHEIMER'S DISEASE. (1st July 2017)
Main Title:: [O2–09–02]: EVALUATION OF SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDI1814, A BETA‐AMYLOID 42 (Aβ42)‐SPECIFIC ANTIBODY, IN PATIENTS WITH MILD‐MODERATE ALZHEIMER'S DISEASE
Authors:: Ostenfeld, Thor
Pomfret, Michael
Billinton, Andy
Chessell, Iain
Chessell, Tharani
Lindqvist, Eva
Valencia, Zulma Santisteban
Groves, Maria
Narwal, Rajesh
Tatipalli, Manasa
Lee, Nancy
Turner, Richard
Tan, Keith
Dudley, Amanda
Abstract:
Is Part Of:: Alzheimer's & dementia. Volume 13:Supplement 7S(2017)Part 11
Journal:: Alzheimer's & dementia
Issue:: Volume 13:Supplement 7S(2017)Part 11
Issue Display:: Volume 13, Issue 7, Part 11 (2017)
Year:: 2017
Volume:: 13
Issue:: 7
Part:: 11
Issue Sort Value:: 2017-0013-0007-0011
Page Start:: P574
Page End:: P574
Publication Date:: 2017-07-01
Subjects:: Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83
Journal URLs:: http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.jalz.2017.07.193 ↗
Languages:: English
ISSNs:: 1552-5260
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13309.xml